S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

VIR Vir Biotechnology Inc

9.73

-0.20 (-2.01%)

May 17 2024 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

Vir Biotechnology (NASDAQ:VIR)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Vir Biotechnology Charts.

Vir Biotechnology (NASDAQ:VIR)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Vir Biotechnology Charts.

Vir Biotechnology Inc News

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 14 May 2024 (4 days ago) • Edgar (US Regulatory)

Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
Thursday 2 May 2024 (2 weeks ago) • Business Wire

Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024
Tuesday 30 April 2024 (3 weeks ago) • Business Wire

Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors
Thursday 18 April 2024 (1 month ago) • Business Wire

Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024
Thursday 11 April 2024 (1 month ago) • Business Wire

Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule
Tuesday 5 March 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Monday 26 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 26 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 26 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 26 February 2024 (3 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Monday 26 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Monday 26 February 2024 (3 months ago) • Edgar (US Regulatory)

More Vir Biotechnology Inc News Articles

Vontobel Financial Produ...

Argentine 5 07 20 Bonds

Roeford Properties

RSE Archive (GM)

Thimble Point Acquisition

DB X-Trackers DJ Euro ST...

TheCurrencyAnalytics

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions